{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:49:46Z","timestamp":1791672586152,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chengdu Medical Research Project","award":["No. 2022442"],"award-info":[{"award-number":["No. 2022442"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00520-026-11335-0","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:18:18Z","timestamp":1791670698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and independent influencing factors of moderate-to-severe cancer-related fatigue (CRF) and its association with Buzhong-Yiqi (BZYQ) use among patients with locally advanced cervical squamous cell carcinoma (LACSCC): a retrospective observational study using propensity-score weighting (PSW) logistic regression model"],"prefix":"10.1007","volume":"34","author":[{"given":"Chan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangdi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary T.","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"key":"11335_CR1","unstructured":"National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: cancer-related fatigue. Version 1.2026. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/fatigue.pdf. Accessed 9 Oct 2026"},{"issue":"9","key":"11335_CR2","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/annonc\/mdw252","volume":"27","author":"JL Vardy","year":"2016","unstructured":"Vardy JL, Dhillon HM, Pond GR et al (2016) Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study. Ann Oncol 27(9):1761\u20131767. https:\/\/doi.org\/10.1093\/annonc\/mdw252","journal-title":"Ann Oncol"},{"issue":"6","key":"11335_CR3","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/annonc\/mdw099","volume":"27","author":"HJ Abrahams","year":"2016","unstructured":"Abrahams HJ, Gielissen MF, Schmits IC et al (2016) Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol 27(6):965\u2013974. https:\/\/doi.org\/10.1093\/annonc\/mdw099","journal-title":"Ann Oncol"},{"issue":"7","key":"11335_CR4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1200\/JCO.2003.08.163","volume":"21","author":"SD Foss\u00e5","year":"2003","unstructured":"Foss\u00e5 SD, Dahl AA, Loge JH (2003) Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol 21(7):1249\u20131254. https:\/\/doi.org\/10.1200\/JCO.2003.08.163","journal-title":"J Clin Oncol"},{"issue":"5","key":"11335_CR5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/annonc\/mdz074","volume":"30","author":"F Joly","year":"2019","unstructured":"Joly F, Ahmed-Lecheheb D, Kalbacher E et al (2019) Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case\/control VIVROVAIRE I study. Ann Oncol 30(5):845\u2013852. https:\/\/doi.org\/10.1093\/annonc\/mdz074","journal-title":"Ann Oncol"},{"issue":"13","key":"11335_CR6","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1002\/cncr.32040","volume":"125","author":"N Mounier","year":"2019","unstructured":"Mounier N, Anthony S, Busson R et al (2019) Long-term fatigue in survivors of non-Hodgkin lymphoma: the Lymphoma Study Association SIMONAL cross-sectional study. Cancer 125(13):2291\u20132299. https:\/\/doi.org\/10.1002\/cncr.32040","journal-title":"Cancer"},{"key":"11335_CR7","doi-asserted-by":"publisher","unstructured":"Jung JY, Lee JM, Kim MS et al (2018) Comparison of fatigue, depression, and anxiety as factors affecting posttreatment health-related quality of life in lung cancer survivors.\u00a0Psychooncology 27(2):465\u2013470. https:\/\/doi.org\/10.1002\/pon.4513","DOI":"10.1002\/pon.4513"},{"issue":"Suppl 3","key":"11335_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-S3-S8","volume":"14","author":"T Islam","year":"2014","unstructured":"Islam T, Dahlui M, Majid HA et al (2014) Factors associated with return to work of breast cancer survivors: a systematic review. BMC Public Health 14(Suppl 3):S8. https:\/\/doi.org\/10.1186\/1471-2458-14-S3-S8","journal-title":"BMC Public Health"},{"key":"11335_CR9","doi-asserted-by":"publisher","unstructured":"Janda M, Gerstner N, Obermair A et al (2000) Quality of life changes during conformal radiation therapy for prostate carcinoma. Cancer 89(6):1322\u20131328. https:\/\/doi.org\/10.1002\/1097-0142(20000915)89:6<1322::aid-cncr18>3.0.co;2-d","DOI":"10.1002\/1097-0142(20000915)89:6<1322::aid-cncr18>3.0.co;2-d"},{"key":"11335_CR10","doi-asserted-by":"publisher","unstructured":"Al Maqbali M, Al Sinani M, Al Naamani Z et al (2021) Prevalence of fatigue in patients with cancer: a systematic review and meta-analysis. J Pain Symptom Manage 61(1):167\u2013189.e14. https:\/\/doi.org\/10.1016\/j.jpainsymman.2020.07.037","DOI":"10.1016\/j.jpainsymman.2020.07.037"},{"key":"11335_CR11","doi-asserted-by":"publisher","unstructured":"Gernier F, Joly F, Klein D et al (2020) Cancer-related fatigue among long-term survivors of breast, cervical, and colorectal cancer: a French registry-based controlled study. Support Care Cancer 28(12):5839\u20135849. https:\/\/doi.org\/10.1007\/s00520-020-05427-8","DOI":"10.1007\/s00520-020-05427-8"},{"issue":"3","key":"11335_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-o","volume":"39","author":"EM Smets","year":"1995","unstructured":"Smets EM, Garssen B, Bonke B et al (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39(3):315\u2013325. https:\/\/doi.org\/10.1016\/0022-3999(94)00125-o","journal-title":"J Psychosom Res"},{"issue":"10","key":"11335_CR13","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s00520-011-1357-8","volume":"20","author":"J Tian","year":"2012","unstructured":"Tian J, Hong JS (2012) Validation of the Chinese version of Multidimensional Fatigue Inventory-20 in Chinese patients with cancer. Support Care Cancer 20(10):2379\u20132383. https:\/\/doi.org\/10.1007\/s00520-011-1357-8","journal-title":"Support Care Cancer"},{"key":"11335_CR14","doi-asserted-by":"publisher","unstructured":"Rashid Z, Sharif I, Khushk IA et al (2021) Evaluation of empathy and fatigue among physicians and surgeons in tertiary care hospitals of Rawalpindi. Pak J Med Sci 37(3):663\u2013667. https:\/\/doi.org\/10.12669\/pjms.37.3.1973","DOI":"10.12669\/pjms.37.3.1973"},{"issue":"1","key":"11335_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/02841860601009430","volume":"46","author":"CL Hagelin","year":"2007","unstructured":"Hagelin CL, Wengstr\u00f6m Y, Runesdotter S et al (2007) The psychometric properties of the Swedish Multidimensional Fatigue Inventory MFI-20 in four different populations. Acta Oncol 46(1):97\u2013104. https:\/\/doi.org\/10.1080\/02841860601009430","journal-title":"Acta Oncol"},{"issue":"4","key":"11335_CR16","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jpainsymman.2013.11.015","volume":"48","author":"T Buss","year":"2014","unstructured":"Buss T, Kruk A, Wi\u015bniewski P et al (2014) Psychometric properties of the Polish version of the Multidimensional Fatigue Inventory-20 in cancer patients. J Pain Symptom Manage 48(4):730\u2013737. https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.11.015","journal-title":"J Pain Symptom Manage"},{"issue":"10","key":"11335_CR17","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1007\/s00520-015-2661-5","volume":"23","author":"P Chandel","year":"2015","unstructured":"Chandel P, Sultan A, Khan KA et al (2015) Validation of the Hindi version of the Multidimensional Fatigue Inventory-20 (MFI-20) in Indian cancer patients. Support Care Cancer 23(10):2957\u20132964. https:\/\/doi.org\/10.1007\/s00520-015-2661-5","journal-title":"Support Care Cancer"},{"key":"11335_CR18","doi-asserted-by":"publisher","unstructured":"Gentile S, Delarozi\u00e8re JC, Favre F et al (2003) Validation of the French 'multidimensional fatigue inventory' (MFI 20). Eur J Cancer Care (Engl) 12(1):58\u201364. https:\/\/doi.org\/10.1046\/j.1365-2354.2003.00295.x","DOI":"10.1046\/j.1365-2354."},{"key":"11335_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3152142","volume":"2018","author":"SW Song","year":"2018","unstructured":"Song SW, Kang SG, Kim KS et al (2018) Reliability and validity of the Korean version of the Multidimensional Fatigue Inventory (MFI-20): a multicenter, cross-sectional study. Pain Res Manag 2018:3152142. https:\/\/doi.org\/10.1155\/2018\/3152142","journal-title":"Pain Res Manag"},{"key":"11335_CR20","doi-asserted-by":"publisher","unstructured":"Ba\u015fo\u011flu F, \u00d6nc\u00fc J, Kuran B et al (2020) The reliability and validity of The Turkish version of Multidimensional Fatigue Inventory-20 for the evaluation of different dimensions of fatigue in patients with fibromyalgia. Turk J Phys Med Rehabil 66(4):436\u2013443. https:\/\/doi.org\/10.5606\/tftrd.2020.5781","DOI":"10.5606\/tftrd.2020.5781"},{"issue":"2","key":"11335_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12282-019-01008-8","volume":"27","author":"F Andic","year":"2020","unstructured":"Andic F, Miller AH, Brown G et al (2020) Instruments for determining clinically relevant fatigue in breast cancer patients during radiotherapy. Breast Cancer (Auckl) 27(2):197\u2013205. https:\/\/doi.org\/10.1007\/s12282-019-01008-8","journal-title":"Breast Cancer (Auckl)"},{"key":"11335_CR22","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","DOI":"10.3322\/caac.21834"},{"key":"11335_CR23","doi-asserted-by":"publisher","unstructured":"Diao X, Guo C, Jin Y et al (2025) Cancer situation in China: an analysis based on the global epidemiological data released in 2024. Cancer Commun (Lond) 45(2):178\u2013197. https:\/\/doi.org\/10.1002\/cac2.12627","DOI":"10.1002\/cac2.12627"},{"key":"11335_CR24","doi-asserted-by":"publisher","unstructured":"Han B, Zheng R, Zeng H et al (2024) Cancer incidence and mortality in China, 2022. J Natl Cancer Cent 4(1):47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006","DOI":"10.1016\/j.jncc.2024.01.006"},{"key":"11335_CR25","doi-asserted-by":"publisher","unstructured":"Green JA, Kirwan JM, Tierney JF et al (2001) Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358(9284):781\u2013786. https:\/\/doi.org\/10.1016\/S0140-6736(01)05965-7","DOI":"10.1016\/S0140-6736(01)05965-7"},{"issue":"35","key":"11335_CR26","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","volume":"26","author":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration","year":"2008","unstructured":"Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration (2008) Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 26(35):5802\u20135812. https:\/\/doi.org\/10.1200\/JCO.2008.16.4368","journal-title":"J Clin Oncol"},{"key":"11335_CR27","doi-asserted-by":"publisher","unstructured":"Colombo N, Dubot C, Lorusso D et al (2021) Pembrolizumab for persistent, recurrent, or metastatic cervical cancer. N Engl J Med 385(20):1856\u20131867. https:\/\/doi.org\/10.1056\/NEJMoa2112435","DOI":"10.1056\/NEJMoa2112435"},{"issue":"6","key":"11335_CR28","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1056\/NEJMoa2112187","volume":"386","author":"KS Tewari","year":"2022","unstructured":"Tewari KS, Monk BJ, Vergote I et al (2022) Survival with cemiplimab in recurrent cervical cancer. N Engl J Med 386(6):544\u2013555. https:\/\/doi.org\/10.1056\/NEJMoa2112187","journal-title":"N Engl J Med"},{"issue":"8","key":"11335_CR29","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJMoa1309748","volume":"370","author":"KS Tewari","year":"2014","unstructured":"Tewari KS, Sill MW, Long HJ 3rd et al (2014) Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 370(8):734\u2013743. https:\/\/doi.org\/10.1056\/NEJMoa1309748","journal-title":"N Engl J Med"},{"key":"11335_CR30","doi-asserted-by":"publisher","unstructured":"Tewari KS, Sill MW, Penson RT et al (2017) Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Lancet 390(10103):1654\u20131663. https:\/\/doi.org\/10.1016\/S0140-6736(17)31607-0","DOI":"10.1016\/S0140-6736(17)31607-0"},{"key":"11335_CR31","unstructured":"National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: management of immune-checkpoint inhibitor-related toxicities. Version 1.2026. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ici_tox.pdf. Accessed 9 Oct 2026"},{"key":"11335_CR32","unstructured":"National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: antiemesis. Version 2.2025. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf. Accessed 9 Oct 2026"},{"issue":"6","key":"11335_CR33","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.annonc.2020.02.016","volume":"31","author":"A Fabi","year":"2020","unstructured":"Fabi A, Bhargava R, Fatigoni S et al (2020) Cancer-related fatigue: ESMO clinical practice guidelines for diagnosis and treatment. Ann Oncol 31(6):713\u2013723. https:\/\/doi.org\/10.1016\/j.annonc.2020.02.016","journal-title":"Ann Oncol"},{"issue":"8","key":"11335_CR34","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.6004\/jnccn.2015.0122","volume":"13","author":"AM Berger","year":"2015","unstructured":"Berger AM, Mooney K, Alvarez-Perez A et al (2015) Cancer-related fatigue, version 2.2015. J Natl Compr Canc Netw 13(8):1012\u20131039. https:\/\/doi.org\/10.6004\/jnccn.2015.0122","journal-title":"J Natl Compr Canc Netw"},{"key":"11335_CR35","doi-asserted-by":"publisher","unstructured":"Hofman M, Ryan JL, Figueroa-Moseley CD et al (2007) Cancer-related fatigue: the scale of the problem. Oncologist 12 Suppl 1:4\u201310. https:\/\/doi.org\/10.1634\/theoncologist.12-S1-4","DOI":"10.1634\/theoncologist.12-S1-4"},{"issue":"10","key":"11335_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","volume":"11","author":"JE Bower","year":"2014","unstructured":"Bower JE (2014) Cancer-related fatigue\u2014mechanisms, risk factors, and treatments. Nat Rev Clin Oncol 11(10):597\u2013609. https:\/\/doi.org\/10.1038\/nrclinonc.2014.127","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"11335_CR37","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/cncr.28434","volume":"120","author":"XS Wang","year":"2014","unstructured":"Wang XS, Zhao F, Fisch MJ et al (2014) Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer 120(3):425\u2013432. https:\/\/doi.org\/10.1002\/cncr.28434","journal-title":"Cancer"},{"issue":"11","key":"11335_CR38","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s JM, Busquets S, Stemmler B et al (2014) Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 14(11):754\u2013762. https:\/\/doi.org\/10.1038\/nrc3829","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"11335_CR39","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/annonc\/mdh235","volume":"15","author":"D Cella","year":"2004","unstructured":"Cella D, Kallich J, McDermott A et al (2004) The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol 15(6):979\u2013986. https:\/\/doi.org\/10.1093\/annonc\/mdh235","journal-title":"Ann Oncol"},{"issue":"5","key":"11335_CR40","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/sj.bjc.6602012","volume":"91","author":"LI Wagner","year":"2004","unstructured":"Wagner LI, Cella D (2004) Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer 91(5):822\u2013828. https:\/\/doi.org\/10.1038\/sj.bjc.6602012","journal-title":"Br J Cancer"},{"key":"11335_CR41","unstructured":"Li G (2005) Pi Wei Lun [Treatise on the spleen and stomach]. Jin-Yuan Dynasty. People's Medical Publishing House,\u00a0Beijing, pp 23\u201325"},{"key":"11335_CR42","unstructured":"Li G (2007) Nei Wai Shang Bian Huo Lun [Clarifying doubts about injury from internal and external causes]. Jin-Yuan Dynasty. People's Medical Publishing House,\u00a0Beijing"},{"key":"11335_CR43","unstructured":"Anonymous (2005) Huang Di Nei Jing: Su Wen [Yellow Emperor's inner canon: basic questions]. Warring States to Han Dynasty. People's Medical Publishing House,\u00a0Beijing"},{"issue":"3","key":"11335_CR44","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ctim.2014.04.007","volume":"22","author":"CX Su","year":"2014","unstructured":"Su CX, Wang LQ, Grant SJ et al (2014) Chinese herbal medicine for cancer-related fatigue: a systematic review of randomized clinical trials. Complement Ther Med 22(3):567\u2013579. https:\/\/doi.org\/10.1016\/j.ctim.2014.04.007","journal-title":"Complement Ther Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11335-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11335-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11335-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:18:19Z","timestamp":1791670699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-11335-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["11335"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11335-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare they have no financial interests.","order":1,"name":"Ethics","label":"Financial interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Chengdu Xinjin District People's Hospital Institutional Review Board. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1084"}}